Zentalis Pharmaceuticals (ZNTL) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.67
-0.57
-0.47
-0.37

Details

Expected EPS
-0.476667
Actual EPS
-0.5
Surprise EPS
-0.02
Surprise Percent
+4.9%

Description

Zentalis Pharmaceuticals (ZNTL) has reported earnings of -0.5 per share for Q2 2026.

0 Comments

Share your thoughts